New York, NY - Global law firm Reed Smith today announced that it represented Sweden-based Nextmune, a portfolio company of Fidelio Capital and the global leader in companion-animal allergy testing on the closing of its acquisition of the U.S. veterinary business activities known as ACTT from ALK, a global, research-driven pharmaceutical company that focuses on prevention, diagnosis, and treatment of allergies.

The Reed Smith Private Equity team on this transaction was comprised of Christopher Sheaffer, Anatoliy Rozental, Nataly Laufer Sultan and Sophie Ha.

For a copy of the press release issued by Nextmune announcing the acquisition, visit

About Reed Smith

Reed Smith is a dynamic international law firm dedicated to helping clients move their businesses forward. Our belief is that by delivering smarter and more creative legal services, we will not only enrich our clients’ experiences with us, but also support them in achieving their business goals.

Our long-standing relationships, international outlook, and collaborative structure make us the go-to partner for the speedy resolution of complex disputes, transactions, and regulatory matters.

For further information, please visit